Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Response Evaluation in Prostate Cancer Using PSMA PET/CT.
Gafita A, Schroeder JA, Ceci F, Oldan JD, Khandani AH, Lecouvet FE, Solnes LB, Rowe SP. Gafita A, et al. Among authors: solnes lb. J Nucl Med. 2025 Jun 5:jnumed.124.268071. doi: 10.2967/jnumed.124.268071. Online ahead of print. J Nucl Med. 2025. PMID: 40473460
ACR Appropriateness Criteria® Inflammatory Ear Disease.
Expert Panel on Neurological Imaging; Agarwal M, Juliano AF, Hagiwara M, Auron M, Burns J, Bush ML, Dubey P, Friedman ER, Gule-Monroe MK, Hatten BW, Jain V, Rath TJ, Solnes LB, Taheri MR, Zander D, Policeni B. Expert Panel on Neurological Imaging, et al. Among authors: solnes lb. J Am Coll Radiol. 2025 May;22(5S):S300-S318. doi: 10.1016/j.jacr.2025.02.026. J Am Coll Radiol. 2025. PMID: 40409884
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data.
Unterrainer LM, De Leiris N, Unterrainer M, Delker A, Hempel L, Ells Z, Kunte SC, Zahner J, Holzgreve A, Zacherl MJ, Sheikh GT, Casuscelli J, Leenhardt J, Pienta KJ, Jacquet E, Laramas M, Long J, Faure M, Reboulet G, Paller CJ, Mercier A, Solnes LB, Kiraz K, Ilhan H, Gafita A, Djaileb L. Unterrainer LM, et al. Among authors: solnes lb. J Nucl Med. 2025 Apr 24:jnumed.124.269431. doi: 10.2967/jnumed.124.269431. Online ahead of print. J Nucl Med. 2025. PMID: 40274370
Diagnostic and theranostic opportunities in Neuro-oncology.
Ritter Z, Oeltzschner G, Solnes LB, Liu G, Kamson DO. Ritter Z, et al. Among authors: solnes lb. Adv Oncol. 2024 May;4(1):111-124. doi: 10.1016/j.yao.2024.01.001. Epub 2024 Jan 29. Adv Oncol. 2024. PMID: 40248613 Free PMC article.
Multiplex Spatial Proteomic Analysis of HER2-Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response.
Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Denbow R, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Winer EP, Krop IE, Wolff AC, Wahl RL, Perez EA, Huang CY, Stearns V, Thompson EA, Connolly RM. Hennessy MA, et al. Among authors: solnes lb. JCO Precis Oncol. 2025 Apr;9:e2400546. doi: 10.1200/PO-24-00546. Epub 2025 Apr 3. JCO Precis Oncol. 2025. PMID: 40179327
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026).
Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Vaklavas C, Krop I, Winer E, Denbow R, Valero V, Wolff AC, Wahl RL, Huang CY, Stearns V, Thompson EA, Connolly RM. Hennessy MA, et al. Among authors: solnes lb. Breast. 2025 Jun;81:104432. doi: 10.1016/j.breast.2025.104432. Epub 2025 Mar 1. Breast. 2025. PMID: 40049115 Free PMC article.
115 results